| Source | EPS | Rev (mil) | Score | Rank |
|---|---|---|---|---|
![[avatar]](http://com.estimize.s3.amazonaws.com/user/avatar/4e966c4dc6efa674f1000171/tiny_Derald_Headshot.jpg){kind=small}
1nvestor
|
1.03 | 531.00 | 19 | 1 / 2 |
| Wall Street Consensus | 1.04 | 531.40 | - | - |
| Estimize Consensus | - | - | ||
| Actual / Reported | 0.96 | 477.50 | - | - |
Estimates for CXO FQ4 2012
![[avatar]](http://com.estimize.s3.amazonaws.com/user/avatar/4f06f982c6efa665af000009/tiny_image.jpg){kind=small}
DrofRx
James Capone
|
CXO | Feb 20 | 1.04 | 532.00 | Feb 19 |
| Source | EPS | Rev (mil) | Score | Rank |
|---|---|---|---|---|
|
1nvestor
|
1.03 | 531.00 | 19 | 1 / 2 |
| Wall Street Consensus | 1.04 | 531.40 | - | - |
| Estimize Consensus | - | - | ||
| Actual / Reported | 0.96 | 477.50 | - | - |
|
DrofRx
James Capone
|
CXO | Feb 20 | 1.04 | 532.00 | Feb 19 |
Copyright © 2013 Estimize. All Rights Reserved.